ET04 - The New Eversense® E3 CGM System: Clues to Choose

Friday, August 12, 2022

5:45 PM – 6:30 PM ET

Location: Room 321

Sponsored By

Please join us and learn what’s new and exciting with the only fully implantable, long term CGM system. Our session will be engaging and interactive with a focus on what Eversense E3 uniquely offers your patients so they may succeed with CGM therapy. Hear straight from a patient describing the advantages of Eversense E3 and why it works for him!

Presenter(s)

Francine R. Kaufman, MD

Cheif Medical Officer
Senseonics, Inc

Disclosure: Disclosure information not submitted.
Gary Scheiner, MS, CDCES

Owner, Clinical Director
Integrated Diabetes Services, LLC
Wynnewood, Pennsylvania

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Chris Ruden

Disclosure: Disclosure information not submitted.